Medicines A–Z
B
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Bee and wasp allergen extracts (Phamalgen) | Hospital only |
|
|
Belatacept powder concentrate for infusion | For hospital use only |
|
|
Belimumab | Hospital use only |
|
|
Belimumab (Benlysta®) | ||
 |
Bempedoic acid (with ezetimibe) | ||
|
Bendamustine injection | ||
|
Bendroflumethiazide tablets | 2.5mg dose (higher doses not indicated in hypertension). Most patients do not develop hypokalaemia. Suggest check potassium level one month after initiation and annually thereafter (MeReC 10/94) |
|
|
Benralizumab | ||
|
Benzathine benzylpenicillin | ||
 |
Benzocaine 20% gel (Ultracare® Bubble Gum) |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
